Concepedia

Ingela Claesson

IC

Statistics

Publications

8

Citations

349

H-Index

8

Active since

1998

Affiliations

University of Gothenburg(Current)

Rigshospitalet

Sahlgrenska University Hospital

Chalmers University of Technology

Ingela Claesson is an author at University of Gothenburg specializing in medicine, oncology, and targeted radionuclide therapy.

Publications per year

1998–2009

8

Publications

8

Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas

Karolina Partheen, Kristina Levan, Lovisa Österberg et al. · International Journal of Cancer · 2008 · 81 citations

, , +17

Therapeutic Efficacy of Astatine-211–Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice

Stig Palm, Tom Bäck, Ingela Claesson et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 72 citations · Full text

, , +17

Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.

Jörgen Elgqvist, Håkan Andersson, Tom Bäck et al. · PubMed · 2006 · 68 citations

, , +15

Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab′)2: therapeutic efficacy and myelotoxicity

Jörgen Elgqvist, Håkan Andersson, Tom Bäck et al. · Nuclear Medicine and Biology · 2006 · 36 citations

, , +17

Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2

Jörgen Elgqvist, Håkan Andersson, Peter Bernhardt et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 34 citations

, , +12

1–5 of 8